Showing results (31-40 of 311) with videos related to
Sort By:
Pageof 32
Journal of Clinical Pharmacology|January 1, 1993
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitorsC Borghi, S Boschi, E Ambrosioni, et al.British Heart Journal|August 1, 1990
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparinG Melandri, A Branzi, F Semprini, et al.Heart (British Cardiac Society)|July 20, 1999
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia terminationM Biffi, G Boriani, G Bronzetti, et al.The American Journal of Cardiology|January 19, 1995
Role of pharmacologic tests in the treatment of primary pulmonary hypertensionN Galiè, G Ussia, P Passarelli, et al.Catheterization and Cardiovascular Diagnosis|August 1, 1997
Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-upA Marzocchi, G Piovaccari, C Marrozzini, et al.European Heart Journal|June 1, 1987
Haemodynamic effects of metoprolol and intravenous nitroglycerin versus metoprolol alone in patients with acute myocardial infarctionG Melandri, A Branzi, F Tartagni, et al.Circulation|December 1, 1993
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trialG Melandri, F Semprini, V Cervi, et al.Cardiologia (Rome, Italy)|May 1, 1992
[Critical mitral stenosis in pregnancy: description of a case treated with percutaneous valvuloplasty]M Zimarino, G Piovaccari, A Marzocchi, et al.The American Journal of Cardiology|May 15, 1997
Results of coronary stenting for unstable versus stable angina pectorisA Marzocchi, G Piovaccari, C Marrozzini, et al.The American Journal of Cardiology|August 15, 1993
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjectsG Melandri, F Semprini, V Cervi, et al.Pageof 32